s6c-sarafotoxin and Leukemia--Megakaryoblastic--Acute

s6c-sarafotoxin has been researched along with Leukemia--Megakaryoblastic--Acute* in 2 studies

Other Studies

2 other study(ies) available for s6c-sarafotoxin and Leukemia--Megakaryoblastic--Acute

ArticleYear
Endothelin expression in human megakaryoblastic leukemia cell lines and normal platelet precursors.
    Regulatory peptides, 1997, Jan-29, Volume: 68, Issue:2

    The aim of the present investigation was to determine whether endothelin (ET) could be expressed in and released from the human leukemia megakaryoblastic cell lines HEL, MEG-01, DAMI and the normal human platelet progenitors. Using the reverse transcriptase-polymerase chain reaction (RT-PCR) on total RNA isolated from the cells, we amplified a cDNA of the expected size (453 bp). Southern-blotting hybridization revealed that RT-PCR products from the cell lines were specific of ET-1 mRNA. Immunocytochemical analyses highlighted immunoreactive ET-1 in the cytoplasm of these cells which also released the mature peptide. ET-1 release from the three cell lines was increased by thrombin exposure. Although MEG-01 cells express ET receptors, ET-1, the selective ETB agonist sarafotoxin 6C and the non-selective ET-receptor antagonist PD 142893 showed no proliferative or antiproliferative action in basal or stimulating medium. This indicated a lack of autocrine ET-mediated effect on growth. These results demonstrate for the first time that human megakaryoblastic leukemia cell lines and normal bone marrow platelet precursors express ET-1 mRNA and release the mature peptide.

    Topics: Blood Platelets; Blotting, Southern; Cell Division; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Hematopoietic Stem Cells; Humans; Immunohistochemistry; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Oligopeptides; Polymerase Chain Reaction; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Thrombin; Tumor Cells, Cultured; Viper Venoms

1997
Effects of endothelins on the human megakaryoblastic cell line MEG-01.
    European journal of pharmacology, 1992, Dec-01, Volume: 227, Issue:4

    Some effects of endothelin-1 (ET-1) were studied on the megakaryoblastic cell line MEG-01. ET-1 induced an elevation of the intracellular levels of Ca2+([Ca2+]i) as measured with the fluorescent indicator indo-1, which consists of an initial transient increase and an ensuing sustained plateau. The plateau phase was abolished by removal of extracellular Ca2+. In addition, ET-1 induced a rapid (within 5 s) increase in the accumulation of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and more delayed increases in Ins(1,3,4)P3 and Ins(1,3,4,5)P4, but did not modify cAMP levels. ET-1 homologues (ET-2, ET-3, sarafotoxin 6b and vasointestinal constrictor) also induced biphasic effects on [Ca2+]i. The Ca2+ elevation was concentration dependent, the order of potency being sarafotoxin 6b > ET-1 > ET-2 = vasointestinal constrictor > ET-3. The actions of ET analogs in raising [Ca2+]i were mutually exclusive, suggesting that they act through the same mechanism. These results suggest that cells of the megakaryoblast/megakaryocyte lineage are targets for endothelins.

    Topics: Calcium; Cell Line; Cyclic AMP; Endothelins; Humans; Inositol Phosphates; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Tumor Cells, Cultured; Viper Venoms

1992